So any of our clients, if they are sending to a local pharmacy, or to a specialist or laboratory, they can "friend" that laboratory or specialist or pharmacy onto athenaNet, and without getting onto any of our other services, that entity can start paying for and receiving online clinical information from our cloud-based service without having to be on it.
At that point, assuming we like the way its coming together, we negotiate a pre-defined exit path for a possible investment: upon successful completion of XYZ clinical study, the Pharma will buyout the asset-centric entity in an upfront plus milestones type transaction.